So far in India, only people above the age of 18 are getting the corona vaccine. So far no concrete decision has been taken regarding the vaccination of children. However, a big news has come out about vaccinating children. All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said that the trial of Covaxin, the corona vaccine of Bharat Biotech Company, being made for children in the country, is going on. According to the AIIMS director, the results of the trial of this vaccine being made for children are expected by September.
Doctor. “Bharat Biotech’s Covaxin trials for children are currently underway and the results are expected to be released by September,” Guleria said on Saturday (July 23).
Dr. Guleria said that schools can be opened in areas where the infection rate is low with full monitoring. In this era of epidemic, many children had to drop out of school due to lack of availability of computers and mobiles.
According to the information, Zydus Cadila has completed the trial of its vaccine for children aged 12 to 18 years. However, it will take a few more days for the Drug Controller General of India (DCGI) to allow it for emergency use.
On the topic of booster dose, Dr. Randeep Guleria said that we may need a booster dose to fight the new forms of the virus as there will be a decline in immunity over time. He made it clear that the booster dose will be the next generation medicine. These second generation vaccines will give excellent immunity, which will be effective and effective against new forms of the virus. These booster doses are currently under trial. According to Randeep Guleria, a booster dose may be needed by the end of this year, but this will happen only once the entire population is vaccinated.
